abstract |
FIELD: pharmacology. n SUBSTANCE: invention relates to pyrazolaminopyrimidine derivatives listed in claim 1 which are modulators of leucine-repeating kinase 2 (LRRK2), a pharmaceutical composition containing them, application of these compounds for treatment of diseases associated with the LRRK2 receptor such as Parkinson's disease, and to a method for Parkinson's disease treatment. n EFFECT: higher efficacy of compound application. n 6 cl, 4 tbl, 52 ex |